ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

New Algorithm Completes Scan Three Times Faster Than Before

November 25, 2011

Howard Hughes Medical Institute Appoints 12 Physician Investigators

May 31, 2002

PR Firm Hired By American Cancer Society Also Represents “Team KOOL Green”.

January 28, 2000